Skip to content
2000
Volume 31, Issue 34
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

As a heterogeneous clinical syndrome, acute respiratory distress syndrome (ARDS) is caused by infection-associated inflammation with limited treatment options. Esketamine possesses anti-inflammatory properties, and it is effective in treating lung diseases.

Objective

This study aimed to unveil the efficacy and mechanism of esketamine in ARDS.

Methods

Lipopolysaccharide (LPS) is widely used to induce inflammatory response in lung injury. The mice model of ARDS in this study was established through the inhalation of LPS. Hematoxylin-eosin (H&E) staining was used to evaluate the pathological changes in the lung tissues of ARDS mice, and the histological index of lung damage was employed. Bicinchoninic acid (BCA) assay kits were utilized to assess the total proteins in bronchoalveolar lavage fluid (BALF), and a hemocytometer was used to count the number of total cells. The pulmonary vascular permeability was detected using Evans blue staining. Western blot was carried out to detect the expressions of tight junction proteins, and enzyme-linked immunosorbent assay (ELISA) detected the release of inflammatory cytokines in BALF and serum. Dihydroethidium (DHE) staining was used to detect reactive oxygen species (ROS) production, and the levels of myeloperoxidase (MPO) and oxidative stress markers were measured using corresponding assay kits. Apoptosis was assessed through terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and Western blot. Immunostaining detected the FUN14 domain-containing 1 (FUNDC1) and light chain 3B (LC3B) in lung tissues, and the expressions of autophagy-related proteins were detected using Western blot.

Results

Our data showed that esketamine treatment alleviated LPS-stimulated lung damage, improved pulmonary vascular permeability, and inhibited inflammatory response, oxidative stress, and apoptosis in ARDS mice. Mechanically, esketamine activated mitophagy through UNC-52-like kinase 1 (ULK1)/FUNDC1 signaling pathway. These findings, for the first time, revealed the therapeutic potential of esketamine in treating ARDS.

Conclusion

Collectively, this study revealed the protective role of esketamine against lung injury, inflammation, oxidative stress, and apoptosis in mice with ARDS and revealed the reaction mechanism related to mitophagy.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128361112250221065359
2025-02-28
2025-09-04

  • From This Site

    /content/journals/cpd/10.2174/0113816128361112250221065359
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cpd/31/34/CPD-31-34-05.html?itemId=/content/journals/cpd/10.2174/0113816128361112250221065359&mimeType=html&fmt=ahah

References

  1. ZhangD. XuC. ZhangJ. Plasma TNFRSF11B as a new predictive inflammatory marker of Sepsis-ARDS with endothelial dysfunction.J. Proteome Res.202322113640365110.1021/acs.jproteome.3c00576 37851947
     [Google Scholar]
  2. WareL.B. MatthayM.A. The acute respiratory distress syndrome.N. Engl. J. Med.2000342181334134910.1056/NEJM200005043421806 10793167
     [Google Scholar]
  3. MeyerN.J. GattinoniL. CalfeeC.S. Acute respiratory distress syndrome.Lancet20213981030062263710.1016/S0140‑6736(21)00439‑6 34217425
     [Google Scholar]
  4. LiuC. XiaoK. XieL. Advances in the regulation of macrophage polarization by mesenchymal stem cells and implications for ALI/ARDS treatment.Front. Immunol.20221392813410.3389/fimmu.2022.928134 35880175
     [Google Scholar]
  5. PatanwalaA.E. MartinJ.R. ErstadB.L. Ketamine for analgosedation in the intensive care unit: A systematic review.J. Intensive Care Med.201732638739510.1177/0885066615620592 26647407
     [Google Scholar]
  6. XuD. SunX. ZhangY. ChaoL. Ketamine alleviates HMGB1-induced acute lung injury through TLR4 signaling pathway.Adv. Clin. Exp. Med.202029781381710.17219/acem/121936 32725973
     [Google Scholar]
  7. Wendel-GarciaP.D. ErlebachR. HofmaennerD.A. Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome.Crit. Care202226114810.1186/s13054‑022‑04019‑8 35606831
     [Google Scholar]
  8. TrimmelH. HelbokR. StaudingerT. S(+)-ketamine.Wien. Klin. Wochenschr.20181309-1035636610.1007/s00508‑017‑1299‑3 29322377
     [Google Scholar]
  9. QiD. TangX. HeJ. Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism.Cell Death Dis.201679e236010.1038/cddis.2016.265 27607575
     [Google Scholar]
  10. ÇomaklıS. KüçüklerS. DeğirmençayŞ. Bolatİ. ÖzdemirS. Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling.Int. Immunopharmacol.202412611126410.1016/j.intimp.2023.111264 38016342
     [Google Scholar]
  11. XuX. LiW. YuZ. Berberine ameliorates dextran sulfate sodium-induced ulcerative colitis and inhibits the secretion of gut lysozyme via promoting autophagy.Metabolites202212867610.3390/metabo12080676 35893243
     [Google Scholar]
  12. FuZ. WuX. ZhengF. ZhangY. Activation of the AMPK-ULK1 pathway mediated protective autophagy by sevoflurane anesthesia restrains LPS-induced acute lung injury (ALI).Int. Immunopharmacol.202210810886910.1016/j.intimp.2022.108869 35605434
     [Google Scholar]
  13. DengR. ZhangH.L. HuangJ.H. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.Autophagy202117103011302910.1080/15548627.2020.1850609 33213267
     [Google Scholar]
  14. WuW. TianW. HuZ. ULK 1 translocates to mitochondria and phosphorylates FUNDC 1 to regulate mitophagy.EMBO Rep.201415556657510.1002/embr.201438501 24671035
     [Google Scholar]
  15. WuY. ZhangY. XieB. ZhangX. WangG. YuanS. Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/] spleen axis.Int. Immunopharmacol.202412611128410.1016/j.intimp.2023.111284 38016344
     [Google Scholar]
  16. ZhouY. HaoC. LiC. Omentin-1 protects against bleomycin-induced acute lung injury.Mol. Immunol.20181039610510.1016/j.molimm.2018.09.007 30245266
     [Google Scholar]
  17. ZengM. SangW. ChenS. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.Toxicol. Lett.2017271263710.1016/j.toxlet.2017.02.023 28245985
     [Google Scholar]
  18. MaX. LiuX. FengJ. Fraxin alleviates LPS-induced ARDS by downregulating inflammatory responses and oxidative damages and reducing pulmonary vascular permeability.Inflammation20194251901191210.1007/s10753‑019‑01052‑8 31273573
     [Google Scholar]
  19. AijazS. BaldaM.S. MatterK. Tight junctions: Molecular architecture and function.Int. Rev. Cytol.200624826129810.1016/S0074‑7696(06)48005‑0 16487793
     [Google Scholar]
  20. JiangY. RosboroughB.R. ChenJ. Single cell RNA sequencing identifies an early monocyte gene signature in acute respiratory distress syndrome.JCI Insight2020513e13567810.1172/jci.insight.135678 32554932
     [Google Scholar]
  21. LiuX. ZhangJ. XieW. The role of ferroptosis in acute lung injury.Mol. Cell. Biochem.202247751453146110.1007/s11010‑021‑04327‑7 35166985
     [Google Scholar]
  22. HeF. GuL. CaiN. The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/] ATF4-mediated endoplasmic reticulum stress.Inflamm. Res.20227110-111245126010.1007/s00011‑022‑01613‑y 35871648
     [Google Scholar]
  23. LiT. LiuY. XuW. Polydatin mediates parkin-dependent mitophagy and protects against mitochondria-dependent apoptosis in acute respiratory distress syndrome.Lab. Invest.201999681982910.1038/s41374‑019‑0191‑3 30808930
     [Google Scholar]
  24. WangX. LingG. WeiY. Activation of ULK1 to trigger FUNDC1-mediated mitophagy in heart failure: Effect of Ginsenoside Rg3 intervention.Phytomedicine202312015504210.1016/j.phymed.2023.155042 37659296
     [Google Scholar]
  25. WuD. ZhangH. LiF. Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation.Biochim. Biophys. Acta, Gen. Subj.20241868713061210.1016/j.bbagen.2024.130612 38626830
     [Google Scholar]
  26. SilvaJ.D. de CastroL.L. BragaC.L. Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology.Stem Cells Int.2019201911510.1155/2019/8262849 31531026
     [Google Scholar]
  27. SchusterD.P. The search for “objective” criteria of ARDS.Intensive Care Med.200733340040210.1007/s00134‑006‑0499‑5 17221188
     [Google Scholar]
  28. WrayC. MaoY. PanJ. ChandrasenaA. PiastaF. FrankJ.A. Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury.Am. J. Physiol. Lung Cell. Mol. Physiol.20092972L219L22710.1152/ajplung.00043.2009 19447895
     [Google Scholar]
  29. HerreroR. PradosL. FerrueloA. Fas activation alters tight junction proteins in acute lung injury.Thorax2019741698210.1136/thoraxjnl‑2018‑211535 30385692
     [Google Scholar]
  30. ChaiJ. LongB. LiuX. Effects of sevoflurane on tight junction protein expression and PKC-α translocation after pulmonary ischemia-reperfusion injury.Exp. Mol. Med.2015476e16710.1038/emm.2015.27 26045255
     [Google Scholar]
  31. GuttmanJ.A. SamjiF.N. LiY. VoglA.W. FinlayB.B. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo.Infect. Immun.200674116075608410.1128/IAI.00721‑06 16954399
     [Google Scholar]
  32. LiuM. GuC. WangY. Upregulation of the tight junction protein occludin: Effects on ventilation-induced lung injury and mechanisms of action.BMC Pulm. Med.20141419410.1186/1471‑2466‑14‑94 24884662
     [Google Scholar]
  33. FrantzeskakiF. ArmaganidisA. OrfanosS.E. Immunothrombosis in acute respiratory distress syndrome: Cross talks between inflammation and coagulation.Respiration201793321222510.1159/000453002 27997925
     [Google Scholar]
  34. ReissL.K. SchuppertA. UhligS. Inflammatory processes during acute respiratory distress syndrome: A complex system.Curr. Opin. Crit. Care20182411910.1097/MCC.0000000000000472 29176329
     [Google Scholar]
  35. ChenP.J. ChenS.H. ChenY.L. Ribociclib leverages phosphodiesterase 4 inhibition in the treatment of neutrophilic inflammation and acute respiratory distress syndrome.J. Adv. Res.20246222924310.1016/j.jare.2024.03.019 38548264
     [Google Scholar]
  36. MillarM.W. FazalF. RahmanA. Therapeutic targeting of NF-κB in acute lung injury: A double-edged sword.Cells20221120331710.3390/cells11203317 36291185
     [Google Scholar]
  37. XiaoS. ZhouY. WangQ. YangD. Ketamine attenuates airway inflammation via inducing inflammatory cells apoptosis and activating Nrf2 pathway in a mixed-granulocytic murine asthma model.Drug Des. Devel. Ther.2022164411442810.2147/DDDT.S391010 36597444
     [Google Scholar]
  38. GonçalvesC.L. AbelairaH.M. RosaT. Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.Pharmacol. Rep.202173252553510.1007/s43440‑020‑00200‑4 33393059
     [Google Scholar]
  39. ZhangH. ChenZ. ZhouJ. NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway.Commun. Biol.20225191610.1038/s42003‑022‑03868‑x 36068299
     [Google Scholar]
  40. ULK1 inhibition restores antigen presentation in LKB1-Mutant lung cancer.Cancer Discov.2021117OF810.1158/2159‑8290.CD‑RW2021‑076 34049942
     [Google Scholar]
  41. D’ArcyM.S. Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications.Apoptosis2024299-101415142810.1007/s10495‑024‑01977‑y 38758472
     [Google Scholar]
  42. GreenD.R. LevineB. To be or not to be? How selective autophagy and cell death govern cell fate.Cell20141571657510.1016/j.cell.2014.02.049 24679527
     [Google Scholar]
  43. SharmaA. AhmadS. AhmadT. AliS. SyedM.A. Mitochondrial dynamics and mitophagy in lung disorders.Life Sci.202128411987610.1016/j.lfs.2021.119876 34389405
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128361112250221065359
Loading
Esketamine Regulates Mitophagy through ULK1/FUNDC1 Signaling Pathway to Improve LPS-induced Acute Respiratory Distress Syndrome
Curr. Pharm. Des. 31, 2774 (2025); https://doi.org/10.2174/0113816128361112250221065359
/content/journals/cpd/10.2174/0113816128361112250221065359
/content/journals/cpd/10.2174/0113816128361112250221065359
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Acute respiratory distress syndrome; dihydroethidium; esketamine; ketamine; mitophagy; ULK1/FUNDC1 signaling pathway

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test